Of the three trusts, RTW Biotech Opportunities (RTW) is the largest, with £841mn in assets, while International Biotechnology ...

With thousands of exchange traded funds (ETFs) available to UK investors, our Top 50 ETFs list aims to give you a practical ...

By the Fed’s reckoning, the US economy is in decent shape. The latest press release, courtesy of new chair Kevin Warsh, was ...

We like to include a selection of ETFs targeting income across different markets, which can be handy for investors who need ...

However, the direction of travel for many UK-listed defence players is still a positive one. Two shares we think are ...

These sectors are both well liked by income investors, and while they are more often associated with active funds and ...

Some Magnificent Seven names were a little stronger to offset, while financials and healthcare shares saw some gains.

We then turn to Britain’s housing market as the cost of homes crept up in June. Hugh Moorhead dives into whether it’s showing signs of meaningful recovery, regional trends and how affordability ...

It has been a good period for long-suffering investors in German conglomerate Bayer (DE:BAYN). The share price has risen by close to 25 per cent over the past month, as investors sensed that an end to ...

His fund has been plagued by underperformance, partly because its quality growth style has been out of favour and partly ...

Economic signals are so noisy at the moment that it is difficult to see the wood for the trees. Are we entering a period of ...

The lack of tech stocks and chipmakers in the FTSE 100 is a boon to British shares this morning, with London’s blue chip ...